Before everyone gets too carried away with share price estimates of $2 etc it's important to note that a positive finding for the phase 2 trial has already been partially factored into the share price.
IF the news isn't as good as everyone expects, then get set for a significant downward correction in the share price. IMO an increase in the share price above $2 prior to the release of the trial results is highly unlikely and whilst it may spike up above $2 post results it probably wont last long as this drug still has a long way (years) to go before it hits the market.
MBP Price at posting:
0.0¢ Sentiment: None Disclosure: Held
